glp 1 stocks 2025 GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Financial Express | A ₹1,000
Description
Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.
Here's a new option to help keep costs down.
Brands that advertise access to weight loss drugs will want to develop messaging for when appointments surge
22, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice
Worried about hair thinning on GLP-1 meds
